Trademark Attorney / Law Firm
Tim Chheda – Trademark Portfolio
Tim Chheda specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 8 of 14 total filings concentrated in this category. The practice also covers Class 30 (Staple Foods) along with 6 other Nice Classification classes. Filing activity spans from 2012 to 2015. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Tim Chheda's trademark practice covers 6 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademark applications has Tim Chheda filed?
Tim Chheda has filed 14 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does Tim Chheda specialize in?
Tim Chheda has filed trademarks across 6 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 35 (Advertising & Business), Class 40 (Treatment & Processing), Class 25 (Clothing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Tim Chheda been filing trademarks?
Tim Chheda's trademark filing history with the USPTO spans from 2012 to 2015, covering 3 years of trademark practice. During this period, Tim Chheda has handled 14 trademark applications.
What is Tim Chheda's trademark registration success rate?
Tim Chheda has a 0% trademark registration rate, with 0 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.